WallStSmart

Boston Scientific Corp (BSX)vsTotalEnergies SE ADR (TTE)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

TotalEnergies SE ADR generates 792% more annual revenue ($183.96B vs $20.61B). BSX leads profitability with a 17.3% profit margin vs 8.2%. BSX appears more attractively valued with a PEG of 0.68. TTE earns a higher WallStSmart Score of 73/100 (B).

BSX

Strong Buy

71

out of 100

Grade: B

Growth: 8.0Profit: 7.0Value: 5.3Quality: 5.5
Piotroski: 4/9

TTE

Strong Buy

73

out of 100

Grade: B

Growth: 5.3Profit: 6.5Value: 7.0Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

BSXSignificantly Overvalued (-21.3%)

Margin of Safety

-21.3%

Fair Value

$46.16

Current Price

$56.00

$9.84 premium

UndervaluedFair: $46.16Overvalued

Intrinsic value data unavailable for TTE.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

BSX5 strengths · Avg: 8.6/10
EPS GrowthGrowth
100.0%10/10

Earnings expanding 100.0% YoY

Market CapQuality
$83.97B9/10

Large-cap with strong market position

PEG RatioValuation
0.688/10

Growing faster than its price suggests

Operating MarginProfitability
20.6%8/10

Strong operational efficiency at 20.6%

Free Cash FlowQuality
$1.01B8/10

Generating 1.0B in free cash flow

TTE6 strengths · Avg: 8.7/10
Market CapQuality
$206.57B10/10

Mega-cap, among the largest globally

EPS GrowthGrowth
57.1%10/10

Earnings expanding 57.1% YoY

PEG RatioValuation
0.788/10

Growing faster than its price suggests

P/E RatioValuation
13.8x8/10

Attractively priced relative to earnings

Price/BookValuation
1.7x8/10

Reasonable price relative to book value

Operating MarginProfitability
20.3%8/10

Strong operational efficiency at 20.3%

Areas to Watch

BSX0 concerns · Avg: 0/10

No major concerns identified

TTE2 concerns · Avg: 3.0/10
Revenue GrowthGrowth
3.4%4/10

3.4% revenue growth

Free Cash FlowQuality
$-1.24B2/10

Negative free cash flow — burning cash

Comparative Analysis Report

WallStSmart Research

Bull Case : BSX

The strongest argument for BSX centers on EPS Growth, Market Cap, PEG Ratio. Profitability is solid with margins at 17.3% and operating margin at 20.6%. Revenue growth of 11.6% demonstrates continued momentum.

Bull Case : TTE

The strongest argument for TTE centers on Market Cap, EPS Growth, PEG Ratio. PEG of 0.78 suggests the stock is reasonably priced for its growth.

Bear Case : BSX

No major red flags identified for BSX, but monitor valuation.

Bear Case : TTE

The primary concerns for TTE are Revenue Growth, Free Cash Flow.

Key Dynamics to Monitor

BSX profiles as a mature stock while TTE is a value play — different risk/reward profiles.

BSX carries more volatility with a beta of 0.78 — expect wider price swings.

BSX is growing revenue faster at 11.6% — sustainability is the question.

BSX generates stronger free cash flow (1.0B), providing more financial flexibility.

Bottom Line

TTE scores higher overall (73/100 vs 71/100). Both earn "Strong Buy" and "Strong Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Boston Scientific Corp

HEALTHCARE · MEDICAL DEVICES · USA

Boston Scientific Corporation, doing business as Boston Scientific, is a manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.

TotalEnergies SE ADR

ENERGY · OIL & GAS INTEGRATED · USA

TotalEnergies SE is a global integrated oil and gas company. The company is headquartered in Paris, France.

Want to dig deeper into these stocks?